D,L-Propranolol and D-propranolol in essential tremor View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1984

AUTHORS

S. Calzetti , L. J. Findley

ABSTRACT

The β-adrenoceptor antagonist D,L-propranolol is the drug of first choice in the symptomatic control of essential tremor (ET) but the mechanism that mediates the tremolytic effect has not been established. Some authors believe that the drug exerts its effect mainly by blocking central and/or peripheral β-adrenergic receptors (Young et al., 1975; Jefferson et al., 1979), but other mechanisms of action unrelated to blockade of β-adrenoceptors have also been postulated (Young et al., 1975; Koch-Weser, 1975). In particular, the possible role of the membrane-stabilising action (MSA) (quinidine-like) is unclear. While an early report claimed that D-propranolol (the D-isomer retaining the MSA of the racemic mixture but virtually devoid of β-adrenoceptor blocking properties) is as effective as D,L-propranolol (McClure and Davis, 1976), a more recent study failed to confirm these findings (Teräväinen and Larsen, 1981). In a previous study (Calzetti et al., 1983) we have demonstrated that a single oral dose of D,L-propranolol (120 mg) significantly reduces the amplitude of ET within 2 h following its administration. The present study was designed to assess under controlled conditions the comparative tremolytic efficacy of D-propranolol and D,L-propranolol on acute administration. More... »

PAGES

261-269

Book

TITLE

Movement Disorders: Tremor

ISBN

978-1-349-06759-6
978-1-349-06757-2

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-349-06757-2_18

DOI

http://dx.doi.org/10.1007/978-1-349-06757-2_18

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1001697548


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "familyName": "Calzetti", 
        "givenName": "S.", 
        "id": "sg:person.01017132256.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017132256.80"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Findley", 
        "givenName": "L. J.", 
        "id": "sg:person.01332070547.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332070547.96"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/ana.410130210", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007458568"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm197511062931902", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017672377"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/jnnp.44.8.677", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024425871"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/jnnp.42.10.904", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035021515"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm197511062931909", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035786653"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.2600680336", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043775521"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.1974.tb00216.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048786680"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1984", 
    "datePublishedReg": "1984-01-01", 
    "description": "The \u03b2-adrenoceptor antagonist D,L-propranolol is the drug of first choice in the symptomatic control of essential tremor (ET) but the mechanism that mediates the tremolytic effect has not been established. Some authors believe that the drug exerts its effect mainly by blocking central and/or peripheral \u03b2-adrenergic receptors (Young et al., 1975; Jefferson et al., 1979), but other mechanisms of action unrelated to blockade of \u03b2-adrenoceptors have also been postulated (Young et al., 1975; Koch-Weser, 1975). In particular, the possible role of the membrane-stabilising action (MSA) (quinidine-like) is unclear. While an early report claimed that D-propranolol (the D-isomer retaining the MSA of the racemic mixture but virtually devoid of \u03b2-adrenoceptor blocking properties) is as effective as D,L-propranolol (McClure and Davis, 1976), a more recent study failed to confirm these findings (Ter\u00e4v\u00e4inen and Larsen, 1981). In a previous study (Calzetti et al., 1983) we have demonstrated that a single oral dose of D,L-propranolol (120 mg) significantly reduces the amplitude of ET within 2 h following its administration. The present study was designed to assess under controlled conditions the comparative tremolytic efficacy of D-propranolol and D,L-propranolol on acute administration.", 
    "editor": [
      {
        "familyName": "Findley", 
        "givenName": "Leslie J.", 
        "type": "Person"
      }, 
      {
        "familyName": "Capildeo", 
        "givenName": "Rudy", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-349-06757-2_18", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-349-06759-6", 
        "978-1-349-06757-2"
      ], 
      "name": "Movement Disorders: Tremor", 
      "type": "Book"
    }, 
    "name": "D,L-Propranolol and D-propranolol in essential tremor", 
    "pagination": "261-269", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-349-06757-2_18"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "08159481bce60a42e116f7a0dff5cfa2c38d064892412f6016c4caaf5fd34a63"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1001697548"
        ]
      }
    ], 
    "publisher": {
      "location": "London", 
      "name": "Palgrave Macmillan UK", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-349-06757-2_18", 
      "https://app.dimensions.ai/details/publication/pub.1001697548"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2019-04-15T23:49", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8697_00000244.jsonl", 
    "type": "Chapter", 
    "url": "http://link.springer.com/10.1007/978-1-349-06757-2_18"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-349-06757-2_18'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-349-06757-2_18'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-349-06757-2_18'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-349-06757-2_18'


 

This table displays all metadata directly associated to this object as RDF triples.

93 TRIPLES      23 PREDICATES      34 URIs      20 LITERALS      8 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-349-06757-2_18 schema:about anzsrc-for:11
2 anzsrc-for:1115
3 schema:author Neb68e9d46dbf402a935f3837a95940e4
4 schema:citation https://doi.org/10.1002/ana.410130210
5 https://doi.org/10.1002/jps.2600680336
6 https://doi.org/10.1056/nejm197511062931902
7 https://doi.org/10.1056/nejm197511062931909
8 https://doi.org/10.1111/j.1365-2125.1974.tb00216.x
9 https://doi.org/10.1136/jnnp.42.10.904
10 https://doi.org/10.1136/jnnp.44.8.677
11 schema:datePublished 1984
12 schema:datePublishedReg 1984-01-01
13 schema:description The β-adrenoceptor antagonist D,L-propranolol is the drug of first choice in the symptomatic control of essential tremor (ET) but the mechanism that mediates the tremolytic effect has not been established. Some authors believe that the drug exerts its effect mainly by blocking central and/or peripheral β-adrenergic receptors (Young et al., 1975; Jefferson et al., 1979), but other mechanisms of action unrelated to blockade of β-adrenoceptors have also been postulated (Young et al., 1975; Koch-Weser, 1975). In particular, the possible role of the membrane-stabilising action (MSA) (quinidine-like) is unclear. While an early report claimed that D-propranolol (the D-isomer retaining the MSA of the racemic mixture but virtually devoid of β-adrenoceptor blocking properties) is as effective as D,L-propranolol (McClure and Davis, 1976), a more recent study failed to confirm these findings (Teräväinen and Larsen, 1981). In a previous study (Calzetti et al., 1983) we have demonstrated that a single oral dose of D,L-propranolol (120 mg) significantly reduces the amplitude of ET within 2 h following its administration. The present study was designed to assess under controlled conditions the comparative tremolytic efficacy of D-propranolol and D,L-propranolol on acute administration.
14 schema:editor Nd7a2f1a51b344d30ba01f26ff12289b7
15 schema:genre chapter
16 schema:inLanguage en
17 schema:isAccessibleForFree false
18 schema:isPartOf N9b7b867200914979a3672c7b6a3b6179
19 schema:name D,L-Propranolol and D-propranolol in essential tremor
20 schema:pagination 261-269
21 schema:productId N43a279c5e1064f01aac2941ec0a37a1f
22 Nedfa7b0f88414c9e8273efa8c6ca5f50
23 Nf2bc12e6774548dc84b41980d16c278a
24 schema:publisher Nde1d6e7d00084c8ca9068a9249c023bb
25 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001697548
26 https://doi.org/10.1007/978-1-349-06757-2_18
27 schema:sdDatePublished 2019-04-15T23:49
28 schema:sdLicense https://scigraph.springernature.com/explorer/license/
29 schema:sdPublisher N438095cd9c0b494e93abefbcda1f95ba
30 schema:url http://link.springer.com/10.1007/978-1-349-06757-2_18
31 sgo:license sg:explorer/license/
32 sgo:sdDataset chapters
33 rdf:type schema:Chapter
34 N0365e0baf10e44e6b6e9a14a54133f63 rdf:first sg:person.01332070547.96
35 rdf:rest rdf:nil
36 N3a8795012e084f3a8ce230d1c7d8f0ea rdf:first N752626db2af544b481dae8d2f16c463c
37 rdf:rest rdf:nil
38 N438095cd9c0b494e93abefbcda1f95ba schema:name Springer Nature - SN SciGraph project
39 rdf:type schema:Organization
40 N43a279c5e1064f01aac2941ec0a37a1f schema:name doi
41 schema:value 10.1007/978-1-349-06757-2_18
42 rdf:type schema:PropertyValue
43 N5c28f174f8984e7fad06a7cd80c1322c schema:familyName Findley
44 schema:givenName Leslie J.
45 rdf:type schema:Person
46 N752626db2af544b481dae8d2f16c463c schema:familyName Capildeo
47 schema:givenName Rudy
48 rdf:type schema:Person
49 N9b7b867200914979a3672c7b6a3b6179 schema:isbn 978-1-349-06757-2
50 978-1-349-06759-6
51 schema:name Movement Disorders: Tremor
52 rdf:type schema:Book
53 Nd7a2f1a51b344d30ba01f26ff12289b7 rdf:first N5c28f174f8984e7fad06a7cd80c1322c
54 rdf:rest N3a8795012e084f3a8ce230d1c7d8f0ea
55 Nde1d6e7d00084c8ca9068a9249c023bb schema:location London
56 schema:name Palgrave Macmillan UK
57 rdf:type schema:Organisation
58 Neb68e9d46dbf402a935f3837a95940e4 rdf:first sg:person.01017132256.80
59 rdf:rest N0365e0baf10e44e6b6e9a14a54133f63
60 Nedfa7b0f88414c9e8273efa8c6ca5f50 schema:name readcube_id
61 schema:value 08159481bce60a42e116f7a0dff5cfa2c38d064892412f6016c4caaf5fd34a63
62 rdf:type schema:PropertyValue
63 Nf2bc12e6774548dc84b41980d16c278a schema:name dimensions_id
64 schema:value pub.1001697548
65 rdf:type schema:PropertyValue
66 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
67 schema:name Medical and Health Sciences
68 rdf:type schema:DefinedTerm
69 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
70 schema:name Pharmacology and Pharmaceutical Sciences
71 rdf:type schema:DefinedTerm
72 sg:person.01017132256.80 schema:familyName Calzetti
73 schema:givenName S.
74 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017132256.80
75 rdf:type schema:Person
76 sg:person.01332070547.96 schema:familyName Findley
77 schema:givenName L. J.
78 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332070547.96
79 rdf:type schema:Person
80 https://doi.org/10.1002/ana.410130210 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007458568
81 rdf:type schema:CreativeWork
82 https://doi.org/10.1002/jps.2600680336 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043775521
83 rdf:type schema:CreativeWork
84 https://doi.org/10.1056/nejm197511062931902 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017672377
85 rdf:type schema:CreativeWork
86 https://doi.org/10.1056/nejm197511062931909 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035786653
87 rdf:type schema:CreativeWork
88 https://doi.org/10.1111/j.1365-2125.1974.tb00216.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1048786680
89 rdf:type schema:CreativeWork
90 https://doi.org/10.1136/jnnp.42.10.904 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035021515
91 rdf:type schema:CreativeWork
92 https://doi.org/10.1136/jnnp.44.8.677 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024425871
93 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...